OPK
NASD OPKO Health, Inc.$1.71 ↑ +0.10 (+6.21%) Trading Up from the previous close of $1.61
- YTD change
- +35.71%
- vs 20-day SMA
- +10.64%
- vs 200-day SMA
- +28.87%
Price ranges
Price & Performance
+0.40 (+33.06%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 85.9% away from all-time highs of $12.15
- OPK is up 36% since the beginning of the year
- OPK is up 14% over the past 12 months
- OPK is up 6% over the past 1 month
- 9% of all OPK investors are betting against OPK
OPK reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +7.3%.
- Previous minute
- +$0.01
- Last hour
- +$0.03
- Last 5 days
- +24.82%
- vs 8-day SMA
- +21.28%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment manages the clinical laboratory operations of BioReference. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and their global pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.